BR122022000127A8 - Método para fornecer um regime terapêutico de dosagem de proteína plasmática e aparelho que compreende instruções armazenadas no mesmo que são configuradas, quando executadas, para fazer com que o aparelho execute um procedimento para determinar um regime de dosagem - Google Patents
Método para fornecer um regime terapêutico de dosagem de proteína plasmática e aparelho que compreende instruções armazenadas no mesmo que são configuradas, quando executadas, para fazer com que o aparelho execute um procedimento para determinar um regime de dosagemInfo
- Publication number
- BR122022000127A8 BR122022000127A8 BR122022000127A BR122022000127A BR122022000127A8 BR 122022000127 A8 BR122022000127 A8 BR 122022000127A8 BR 122022000127 A BR122022000127 A BR 122022000127A BR 122022000127 A BR122022000127 A BR 122022000127A BR 122022000127 A8 BR122022000127 A8 BR 122022000127A8
- Authority
- BR
- Brazil
- Prior art keywords
- dosage
- plasma protein
- regime
- dosing regimen
- appliance
- Prior art date
Links
- 102000004506 Blood Proteins Human genes 0.000 title abstract 4
- 108010017384 Blood Proteins Proteins 0.000 title abstract 4
- 230000001225 therapeutic effect Effects 0.000 title abstract 4
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/50—Mutagenesis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/30—Unsupervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
- G16B5/20—Probabilistic models
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C99/00—Subject matter not provided for in other groups of this subclass
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Theoretical Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Data Mining & Analysis (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Primary Health Care (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Databases & Information Systems (AREA)
- Computing Systems (AREA)
- Physiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Artificial Intelligence (AREA)
- Evolutionary Computation (AREA)
- Bioethics (AREA)
- Software Systems (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361837421P | 2013-06-20 | 2013-06-20 | |
| US201361840969P | 2013-06-28 | 2013-06-28 | |
| US201361881214P | 2013-09-23 | 2013-09-23 | |
| PCT/US2014/043517 WO2015006033A1 (en) | 2013-06-20 | 2014-06-20 | Providing a pharmacokinetic drug dosing regime |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR122022000127A2 BR122022000127A2 (https=) | 2017-07-25 |
| BR122022000127A8 true BR122022000127A8 (pt) | 2022-08-30 |
Family
ID=52111779
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR122022000127A BR122022000127A8 (pt) | 2013-06-20 | 2014-06-20 | Método para fornecer um regime terapêutico de dosagem de proteína plasmática e aparelho que compreende instruções armazenadas no mesmo que são configuradas, quando executadas, para fazer com que o aparelho execute um procedimento para determinar um regime de dosagem |
| BR112015031856A BR112015031856A8 (pt) | 2013-06-20 | 2014-06-20 | Aparelho para prover um regime de dosagem de proteína plasmática terapêutica e dispositivo acessível à máquina |
| BR122020013811A BR122020013811A8 (pt) | 2013-06-20 | 2014-06-20 | Aparelho para fornecer um regime de dosagem de proteína plasmática terapêutica |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015031856A BR112015031856A8 (pt) | 2013-06-20 | 2014-06-20 | Aparelho para prover um regime de dosagem de proteína plasmática terapêutica e dispositivo acessível à máquina |
| BR122020013811A BR122020013811A8 (pt) | 2013-06-20 | 2014-06-20 | Aparelho para fornecer um regime de dosagem de proteína plasmática terapêutica |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20140379629A1 (https=) |
| EP (3) | EP3879534A1 (https=) |
| JP (4) | JP2016526542A (https=) |
| KR (4) | KR102296042B1 (https=) |
| CN (2) | CN105592973B (https=) |
| AU (3) | AU2014287706B2 (https=) |
| BR (3) | BR122022000127A8 (https=) |
| CA (1) | CA2915472C (https=) |
| CL (1) | CL2015003641A1 (https=) |
| EA (1) | EA037962B1 (https=) |
| ES (1) | ES2882832T3 (https=) |
| GE (4) | GEAP201814039A (https=) |
| IL (3) | IL279313B (https=) |
| MX (3) | MX373454B (https=) |
| MY (2) | MY176173A (https=) |
| NZ (1) | NZ715216A (https=) |
| PH (1) | PH12015502800B1 (https=) |
| PL (1) | PL3010681T3 (https=) |
| SA (2) | SA515370289B1 (https=) |
| SG (1) | SG11201510515YA (https=) |
| UA (1) | UA118109C2 (https=) |
| WO (1) | WO2015006033A1 (https=) |
| ZA (1) | ZA201600100B (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013088318A1 (en) * | 2011-12-13 | 2013-06-20 | Koninklijke Philips Electronics N.V. | Dose optimization based on outcome quality |
| US10083400B2 (en) | 2012-10-05 | 2018-09-25 | Diane R. MOULD | System and method for providing patient-specific dosing as a function of mathematical models updated to account for an observed patient response |
| US10325687B2 (en) * | 2013-12-06 | 2019-06-18 | Bioverativ Therapeutics Inc. | Population pharmacokinetics tools and uses thereof |
| CA2944909A1 (en) | 2014-04-04 | 2015-10-08 | Bloodworks | Routine laboratory and point-of-care (poc) testing for hemostasis |
| US11062797B2 (en) * | 2014-10-10 | 2021-07-13 | Continuous Precision Medicine | Method and system for obtaining and using pharmacokinetic data in drug administration |
| AU2016245862A1 (en) | 2015-04-09 | 2018-02-22 | Diane R. Mould | Systems and methods for patient-specific dosing |
| WO2017136583A1 (en) * | 2016-02-02 | 2017-08-10 | Versartis, Inc. | Growth hormone treatment adherence system |
| KR102415992B1 (ko) | 2016-04-15 | 2022-07-04 | 다케다 야쿠힌 고교 가부시키가이샤 | 약물동역학 약물 투약 요법을 제공하는 방법 및 장치 |
| JP6807015B2 (ja) * | 2016-06-13 | 2021-01-06 | ソニー株式会社 | 情報処理装置、情報処理方法、およびプログラム |
| US10896749B2 (en) * | 2017-01-27 | 2021-01-19 | Shire Human Genetic Therapies, Inc. | Drug monitoring tool |
| US20190365317A1 (en) * | 2017-02-01 | 2019-12-05 | Shire Human Genetic Therapies, Inc. | Physiological sensing and therapeutic administration system and method |
| WO2020163441A1 (en) * | 2019-02-06 | 2020-08-13 | Optimdosing Llc | Smart multidosing |
| BE1027052A1 (fr) | 2019-02-14 | 2020-09-07 | Aardex Group | Procede d'assistance a la prise ou a l'acte d'un traitement therapeutique |
| US10970651B1 (en) * | 2019-12-02 | 2021-04-06 | Sas Institute Inc. | Analytic system for two-stage interactive graphical model selection |
| KR102420872B1 (ko) * | 2020-12-18 | 2022-07-14 | 포항공과대학교 산학협력단 | 강화학습과 약동-약력학 모델을 이용한 연속 약물 투여량 결정 방법 |
| CN113053508B (zh) * | 2021-03-29 | 2024-07-26 | 深圳市科曼医疗设备有限公司 | 基于触控屏的交互控制方法及装置 |
| US12444172B2 (en) * | 2022-11-28 | 2025-10-14 | GE Precision Healthcare LLC | Variable confidence machine learning |
| CN116844662B (zh) * | 2023-06-29 | 2026-03-27 | 中国科学技术大学 | 一种药剂投加方案的选取方法、装置和计算机可读介质 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07124125A (ja) * | 1993-11-04 | 1995-05-16 | S R L:Kk | 薬物投与解析システム |
| SI0796623T1 (en) * | 1996-03-20 | 2005-10-31 | Baxter Aktiengesellschaft | Pharmaceutical preparation for the treatment of blood coagulation disorders |
| CA2218200A1 (en) * | 1996-12-09 | 1998-06-09 | Samuel David | Gpi-ceruloplasmin, analogs thereof, and methods of use |
| US6747002B2 (en) * | 1999-05-11 | 2004-06-08 | Ortho-Mcneil Pharmaceutical, Inc. | Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
| US7860583B2 (en) | 2004-08-25 | 2010-12-28 | Carefusion 303, Inc. | System and method for dynamically adjusting patient therapy |
| AU2002212273B2 (en) * | 2000-09-15 | 2007-06-14 | Aaron Diamond Aids Research Centre | System and method for optimizing drug therapy for the treatment of diseases |
| TW200422917A (en) * | 2003-02-01 | 2004-11-01 | Baxter Int | Wireless medical data communication system and method |
| EP1642607A1 (en) * | 2004-10-04 | 2006-04-05 | Sanofi-Aventis Deutschland GmbH | Dose display mechanism for a drug delivery device |
| JP2006155071A (ja) * | 2004-11-26 | 2006-06-15 | Toshiba Sumiden Medical Information Systems Corp | 電子カルテ薬物療法指示実施システム |
| US20060183786A1 (en) * | 2005-02-16 | 2006-08-17 | Chi Mei Foundation Hospital | Injectable long-acting analgesic composition comprising an ester derivative of ketorolac |
| EP3703058A1 (en) * | 2005-11-29 | 2020-09-02 | Children's Hospital Medical Center | A method of selecting a medication for a patient |
| EP2286359A2 (en) * | 2008-03-27 | 2011-02-23 | Medtronic, Inc. | Method and system to define patient specific therapeutic regimens by means of pharmacokinetic and pharmacodynamic tools |
| US8591454B2 (en) * | 2008-11-10 | 2013-11-26 | The Invention Science Fund I, Llc | Administering a therapeutic agent with more than one taggant |
| PL3326643T3 (pl) | 2009-12-06 | 2021-10-25 | Bioverativ Therapeutics Inc. | Chimeryczne i hybrydowe polipeptydy czynnika VIII-FC oraz sposoby ich zastosowania |
-
2014
- 2014-06-20 WO PCT/US2014/043517 patent/WO2015006033A1/en not_active Ceased
- 2014-06-20 KR KR1020167001142A patent/KR102296042B1/ko active Active
- 2014-06-20 KR KR1020227015723A patent/KR20220065097A/ko not_active Ceased
- 2014-06-20 BR BR122022000127A patent/BR122022000127A8/pt not_active Application Discontinuation
- 2014-06-20 AU AU2014287706A patent/AU2014287706B2/en active Active
- 2014-06-20 GE GEAP201814039A patent/GEAP201814039A/en unknown
- 2014-06-20 GE GEAP201914559A patent/GEAP201914559A/en unknown
- 2014-06-20 BR BR112015031856A patent/BR112015031856A8/pt not_active Application Discontinuation
- 2014-06-20 EP EP21170633.8A patent/EP3879534A1/en active Pending
- 2014-06-20 JP JP2016521871A patent/JP2016526542A/ja active Pending
- 2014-06-20 CN CN201480046279.5A patent/CN105592973B/zh active Active
- 2014-06-20 SG SG11201510515YA patent/SG11201510515YA/en unknown
- 2014-06-20 EP EP14823224.2A patent/EP3010681B1/en active Active
- 2014-06-20 CN CN202010499366.3A patent/CN111508557B/zh active Active
- 2014-06-20 UA UAA201600443A patent/UA118109C2/uk unknown
- 2014-06-20 KR KR1020217026984A patent/KR102352133B1/ko active Active
- 2014-06-20 EP EP17197995.8A patent/EP3309696A1/en not_active Withdrawn
- 2014-06-20 GE GEAP201414039A patent/GEP20186882B/en unknown
- 2014-06-20 EA EA201690048A patent/EA037962B1/ru unknown
- 2014-06-20 MY MYPI2015704622A patent/MY176173A/en unknown
- 2014-06-20 MX MX2015017878A patent/MX373454B/es active IP Right Grant
- 2014-06-20 KR KR1020227001162A patent/KR102397974B1/ko active Active
- 2014-06-20 IL IL279313A patent/IL279313B/en unknown
- 2014-06-20 ES ES14823224T patent/ES2882832T3/es active Active
- 2014-06-20 PL PL14823224T patent/PL3010681T3/pl unknown
- 2014-06-20 NZ NZ715216A patent/NZ715216A/en unknown
- 2014-06-20 CA CA2915472A patent/CA2915472C/en active Active
- 2014-06-20 BR BR122020013811A patent/BR122020013811A8/pt not_active Application Discontinuation
- 2014-06-20 MY MYPI2020003916A patent/MY195911A/en unknown
- 2014-06-20 US US14/311,113 patent/US20140379629A1/en not_active Abandoned
- 2014-06-20 GE GEAP201414559A patent/GEP20196990B/en unknown
-
2015
- 2015-12-16 PH PH12015502800A patent/PH12015502800B1/en unknown
- 2015-12-16 CL CL2015003641A patent/CL2015003641A1/es unknown
- 2015-12-17 SA SA515370289A patent/SA515370289B1/ar unknown
- 2015-12-17 IL IL243208A patent/IL243208B/en active IP Right Grant
- 2015-12-17 SA SA521430246A patent/SA521430246B1/ar unknown
- 2015-12-18 MX MX2023000359A patent/MX2023000359A/es unknown
- 2015-12-18 MX MX2020004112A patent/MX2020004112A/es unknown
-
2016
- 2016-01-06 ZA ZA2016/00100A patent/ZA201600100B/en unknown
-
2017
- 2017-12-07 AU AU2017272293A patent/AU2017272293B2/en active Active
-
2019
- 2019-05-22 JP JP2019095949A patent/JP6813237B2/ja active Active
-
2020
- 2020-04-21 AU AU2020202664A patent/AU2020202664B2/en active Active
- 2020-05-21 IL IL274848A patent/IL274848A/en active IP Right Grant
- 2020-12-11 JP JP2020205945A patent/JP7060291B2/ja active Active
-
2022
- 2022-04-11 JP JP2022065039A patent/JP7398031B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR122022000127A8 (pt) | Método para fornecer um regime terapêutico de dosagem de proteína plasmática e aparelho que compreende instruções armazenadas no mesmo que são configuradas, quando executadas, para fazer com que o aparelho execute um procedimento para determinar um regime de dosagem | |
| CY1123688T1 (el) | Μεθοδοι για τη θεραπευτικη αντιμετωπιση ογκων χρησιμοποιωντας αμφιειδικο αντισωμα cd3xcd20 | |
| BR112014019386A8 (pt) | Dispositivo suplementar para a fixação a um dispositivo de injeção | |
| BR112014018924A8 (pt) | Método de gerar uma etiqueta de dosagem customizada para um dispositivo de distribuição de medicamento | |
| MX384129B (es) | Equipo de combinación de dosis de seguridad y jeringa de seguridad. | |
| SG10201804607RA (en) | System and method for facilitating delivery of patient-care | |
| BR112018011803A2 (pt) | método e mecanismo para a administração de gases incluindo óxido nítrico | |
| BR112013033943A2 (pt) | sistema para uso com uma ou mais fontes de dados filiados de paciente, métodos para atualizar um conjunto de dados de orientação específico de paciente, atualizar uma pluralidade de bancos de dados de dispositivos de interface de paciente, operar um dispositivo de interface de paciente, administrar dados em um sistema, e, dispositivo de interface de paciente | |
| MX382917B (es) | Formulaciones de proteínas líquidas que contienen líquidos iónicos. | |
| MX2021011813A (es) | Sistemas y metodos para compensar a largo plazo la sensibilidad de la deriva de sensores electroquimicos de gas expuestos a oxido nitrico. | |
| BR112014018439A8 (pt) | Terapias de reposição de hormônio transdérmica | |
| EA201591679A1 (ru) | Способ нетоксического лечения абстиненции, вызванной лекарственным средством | |
| MX2025007908A (es) | Aparatos, metodos y sistemas para administrar medicamento utilizando kits de medicamento | |
| CL2016000641A1 (es) | Un controlador para un dispositivo para administrar un medio de contraste que comprende un agente de contraste radiológico en un paciente usando un inyector, y método para determinar el volumen óptimo de un medio de contraste que comprende un agente de contraste radiológico que ha de administrarse en un paciente, antes de la administración. | |
| MX2017008000A (es) | Sistema de inyeccion de un solo uso. | |
| EP3020395A4 (en) | METHOD FOR THE PRODUCTION OF A MICRO-DROP PILLION ACCORDING TO THE TYPE OF TRADITIONAL CHINESE MEDICINE AND MICRO-TROUT PILL MADE BY THIS PROCEDURE ACCORDING TO THE TYPE OF TRADITIONAL CHINESE MEDICINE | |
| BR112017022984A2 (pt) | dispositivo para facilitar o posicionamento de um cateter para administrar um medicamento em um paciente que esteja respirando espontaneamente | |
| BR112017010721A2 (pt) | seringa e método de identificação de uma dosagem precisa de medicamento em uma câmara de dosagem de uma seringa | |
| EA202190596A3 (ru) | Предоставление фармакокинетической схемы дозирования лекарственного средства | |
| Martinelli | Chlorambucil/rituximab | |
| FI20155274A7 (fi) | Adaptiivinen lääkityksen aikataulutus | |
| TH160649A (th) | เครื่องและวิธีการสำหรับข้อกำหนดการให้ขนาดยาทางเภสัชจลนศาสตร์ | |
| UA86912U (ru) | Способ измерения объема амиотрофий (дефицита мышц) на кистях и предплечьях у больных с амиотрофиями |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B15K | Others concerning applications: alteration of classification |
Free format text: AS CLASSIFICACOES ANTERIORES ERAM: B23P 17/04 , A61M 5/31 Ipc: G16H 20/17 (2006.01), G06N 7/00 (2006.01), A61P 7/ |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B12B | Appeal against refusal [chapter 12.2 patent gazette] |